Logo image of MEG

MONTROSE ENVIRONMENTAL GROUP (MEG) Stock Fundamental Analysis

USA - NYSE:MEG - US6151111019 - Common Stock

29.93 USD
+0.87 (+2.99%)
Last: 10/14/2025, 8:04:01 PM
29.93 USD
0 (0%)
After Hours: 10/14/2025, 8:04:01 PM
Fundamental Rating

3

Overall MEG gets a fundamental rating of 3 out of 10. We evaluated MEG against 84 industry peers in the Commercial Services & Supplies industry. While MEG seems to be doing ok healthwise, there are quite some concerns on its profitability. MEG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MEG has reported negative net income.
In the past year MEG had a positive cash flow from operations.
In the past 5 years MEG always reported negative net income.
In the past 5 years MEG always reported a positive cash flow from operatings.
MEG Yearly Net Income VS EBIT VS OCF VS FCFMEG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

MEG's Return On Assets of -4.95% is on the low side compared to the rest of the industry. MEG is outperformed by 65.48% of its industry peers.
MEG's Return On Equity of -9.81% is on the low side compared to the rest of the industry. MEG is outperformed by 61.90% of its industry peers.
Industry RankSector Rank
ROA -4.95%
ROE -9.81%
ROIC N/A
ROA(3y)-6.43%
ROA(5y)-8.4%
ROE(3y)-11.31%
ROE(5y)-15.93%
ROIC(3y)N/A
ROIC(5y)N/A
MEG Yearly ROA, ROE, ROICMEG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

The Gross Margin of MEG (41.19%) is better than 70.24% of its industry peers.
MEG's Gross Margin has improved in the last couple of years.
MEG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.16%
GM growth 5Y5.98%
MEG Yearly Profit, Operating, Gross MarginsMEG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

MEG does not have a ROIC to compare to the WACC, probably because it is not profitable.
MEG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MEG has more shares outstanding
The debt/assets ratio for MEG is higher compared to a year ago.
MEG Yearly Shares OutstandingMEG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MEG Yearly Total Debt VS Total AssetsMEG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

MEG has an Altman-Z score of 1.74. This is a bad value and indicates that MEG is not financially healthy and even has some risk of bankruptcy.
MEG has a Altman-Z score (1.74) which is in line with its industry peers.
MEG has a debt to FCF ratio of 4.96. This is a neutral value as MEG would need 4.96 years to pay back of all of its debts.
MEG's Debt to FCF ratio of 4.96 is fine compared to the rest of the industry. MEG outperforms 70.24% of its industry peers.
MEG has a Debt/Equity ratio of 0.55. This is a neutral value indicating MEG is somewhat dependend on debt financing.
The Debt to Equity ratio of MEG (0.55) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.96
Altman-Z 1.74
ROIC/WACCN/A
WACC8.19%
MEG Yearly LT Debt VS Equity VS FCFMEG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

MEG has a Current Ratio of 1.78. This is a normal value and indicates that MEG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.78, MEG is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
MEG has a Quick Ratio of 1.76. This is a normal value and indicates that MEG is financially healthy and should not expect problems in meeting its short term obligations.
MEG has a Quick ratio of 1.76. This is in the better half of the industry: MEG outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.76
MEG Yearly Current Assets VS Current LiabilitesMEG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for MEG have decreased by -1.34% in the last year.
Looking at the last year, MEG shows a quite strong growth in Revenue. The Revenue has grown by 17.79% in the last year.
MEG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.38% yearly.
EPS 1Y (TTM)-1.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%207.69%
Revenue 1Y (TTM)17.79%
Revenue growth 3Y8.42%
Revenue growth 5Y24.38%
Sales Q2Q%35.32%

3.2 Future

MEG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.41% yearly.
MEG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.01% yearly.
EPS Next Y88.57%
EPS Next 2Y41.18%
EPS Next 3Y25.41%
EPS Next 5YN/A
Revenue Next Year16.3%
Revenue Next 2Y9.71%
Revenue Next 3Y7.49%
Revenue Next 5Y13.01%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MEG Yearly Revenue VS EstimatesMEG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
MEG Yearly EPS VS EstimatesMEG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MEG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MEG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MEG Price Earnings VS Forward Price EarningsMEG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K

4.2 Price Multiples

61.90% of the companies in the same industry are cheaper than MEG, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MEG is valued a bit cheaper than 77.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18
EV/EBITDA 31.6
MEG Per share dataMEG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

MEG's earnings are expected to grow with 25.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.18%
EPS Next 3Y25.41%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MEG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONTROSE ENVIRONMENTAL GROUP

NYSE:MEG (10/14/2025, 8:04:01 PM)

After market: 29.93 0 (0%)

29.93

+0.87 (+2.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners99.94%
Inst Owner Change0%
Ins Owners6.9%
Ins Owner Change0.06%
Market Cap1.06B
Analysts78.33
Price Target33.83 (13.03%)
Short Float %7.57%
Short Ratio5.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP-16.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)144.11%
Min EPS beat(2)-30.65%
Max EPS beat(2)318.86%
EPS beat(4)1
Avg EPS beat(4)-24.22%
Min EPS beat(4)-313.73%
Max EPS beat(4)318.86%
EPS beat(8)2
Avg EPS beat(8)-26.02%
EPS beat(12)2
Avg EPS beat(12)-37.32%
EPS beat(16)4
Avg EPS beat(16)-40.44%
Revenue beat(2)2
Avg Revenue beat(2)14.04%
Min Revenue beat(2)4.73%
Max Revenue beat(2)23.35%
Revenue beat(4)2
Avg Revenue beat(4)5.82%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)23.35%
Revenue beat(8)4
Avg Revenue beat(8)3.07%
Revenue beat(12)5
Avg Revenue beat(12)1.45%
Revenue beat(16)9
Avg Revenue beat(16)2.82%
PT rev (1m)7.86%
PT rev (3m)15.58%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)108.57%
EPS NY rev (1m)-56.25%
EPS NY rev (3m)75.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.35
P/FCF 18
P/OCF 14.93
P/B 2.1
P/tB N/A
EV/EBITDA 31.6
EPS(TTM)-1.51
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)1.66
FCFY5.55%
OCF(TTM)2.01
OCFY6.7%
SpS22.11
BVpS14.28
TBVpS-2.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.95%
ROE -9.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.19%
FCFM 7.52%
ROA(3y)-6.43%
ROA(5y)-8.4%
ROE(3y)-11.31%
ROE(5y)-15.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.16%
GM growth 5Y5.98%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.96
Debt/EBITDA 6.7
Cap/Depr 22.12%
Cap/Sales 1.55%
Interest Coverage N/A
Cash Conversion 171.19%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.76
Altman-Z 1.74
F-Score5
WACC8.19%
ROIC/WACCN/A
Cap/Depr(3y)46.06%
Cap/Depr(5y)35.19%
Cap/Sales(3y)3.51%
Cap/Sales(5y)2.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%207.69%
EPS Next Y88.57%
EPS Next 2Y41.18%
EPS Next 3Y25.41%
EPS Next 5YN/A
Revenue 1Y (TTM)17.79%
Revenue growth 3Y8.42%
Revenue growth 5Y24.38%
Sales Q2Q%35.32%
Revenue Next Year16.3%
Revenue Next 2Y9.71%
Revenue Next 3Y7.49%
Revenue Next 5Y13.01%
EBIT growth 1Y27.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year923.55%
EBIT Next 3Y123.78%
EBIT Next 5Y76.48%
FCF growth 1Y212.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.11%
OCF growth 3Y-16.05%
OCF growth 5Y5.47%